RxDoctor Payments Data

Shiv Patel, MD

Urology · Annapolis, MDNPI 1619262250

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.5%), grants and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 21.5%. Reporting peaked in 2020 at $3,727 and has fallen 73.4% since, to $992 in 2025.

$8,323in general payments, 2019–2025

Across 128 payments — averaging $65.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Medtronic$2K
  • Neotract Inc.$988
  • Dornier Medtech America, Inc$737
  • Dendreon Pharmaceuticals LLC$335
  • Sumitomo Pharma America, Inc.$328
  • plus $2K from 31 others

What the payments were for

  • Grants$3,33440%
  • Travel & lodging$82510%
  • Food & beverage$3,87247%
  • Education$2934%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,323 in reported general payments places this provider in the 65th percentile of 274 urology providers in Maryland.

See all urology providers in Maryland →

Medicare billing

Part B allowed, 2024
$426,198
Medicare patients
1,010
Services billed
7,797

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl208$3,379
Alfuzosin Hcl ErAlfuzosin Hcl18$628
Finasteride16$194
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst14$129
Ciprofloxacin Hcl32$86
CefuroximeCefuroxime Axetil26$84
Oxybutynin Chloride15$64
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim19$39

Paid to pharmacies, not to this prescriber.

Other urology in Annapolis

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →